CN113440612A - Photodynamic enhanced polymer nanogel, preparation method and application thereof - Google Patents
Photodynamic enhanced polymer nanogel, preparation method and application thereof Download PDFInfo
- Publication number
- CN113440612A CN113440612A CN202110684381.XA CN202110684381A CN113440612A CN 113440612 A CN113440612 A CN 113440612A CN 202110684381 A CN202110684381 A CN 202110684381A CN 113440612 A CN113440612 A CN 113440612A
- Authority
- CN
- China
- Prior art keywords
- porphyrin
- photodynamic
- reaction
- nanogel
- polyethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 84
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims abstract description 81
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims abstract description 58
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical class COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 39
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 32
- 150000004033 porphyrin derivatives Chemical class 0.000 claims abstract description 28
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 239000002904 solvent Substances 0.000 claims description 31
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 22
- 239000011230 binding agent Substances 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical group [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 15
- 150000004032 porphyrins Chemical class 0.000 claims description 14
- 239000003054 catalyst Substances 0.000 claims description 12
- -1 tetrahydroxyhexyl ether phenyl porphyrin Chemical group 0.000 claims description 11
- QBQQANPKYCNDDH-UHFFFAOYSA-N OC=1C2=C(C3=C(C(=C(N3O)C=C3C=CC(C=C4C=CC(=CC(C1)=N2)N4)=N3)C3=CC=CC=C3)O)O Chemical compound OC=1C2=C(C3=C(C(=C(N3O)C=C3C=CC(C=C4C=CC(=CC(C1)=N2)N4)=N3)C3=CC=CC=C3)O)O QBQQANPKYCNDDH-UHFFFAOYSA-N 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- JNTPTNNCGDAGEJ-UHFFFAOYSA-N 6-chlorohexan-1-ol Chemical compound OCCCCCCCl JNTPTNNCGDAGEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000007795 chemical reaction product Substances 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical group CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 5
- 235000009518 sodium iodide Nutrition 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000000967 suction filtration Methods 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 3
- 229940041181 antineoplastic drug Drugs 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 230000003321 amplification Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 239000003504 photosensitizing agent Substances 0.000 abstract description 22
- 238000003392 chemiluminescence resonance energy transfer Methods 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract description 4
- 239000002105 nanoparticle Substances 0.000 abstract description 4
- 238000002428 photodynamic therapy Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 230000004614 tumor growth Effects 0.000 abstract description 3
- 238000010276 construction Methods 0.000 abstract description 2
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 79
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 64
- 239000000203 mixture Substances 0.000 description 38
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 229910052757 nitrogen Inorganic materials 0.000 description 32
- 230000015572 biosynthetic process Effects 0.000 description 21
- 238000003786 synthesis reaction Methods 0.000 description 21
- 238000010992 reflux Methods 0.000 description 20
- 238000004108 freeze drying Methods 0.000 description 17
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 8
- QCWPXJXDPFRUGF-UHFFFAOYSA-N N1C=2C=C(N=3)C=CC=3C=C(N3)C=CC3=CC(=N3)C=CC3=CC1=CC=2C1=CC=CC=C1 Chemical class N1C=2C=C(N=3)C=CC=3C=C(N3)C=CC3=CC(=N3)C=CC3=CC1=CC=2C1=CC=CC=C1 QCWPXJXDPFRUGF-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 241001529936 Murinae Species 0.000 description 7
- 201000001441 melanoma Diseases 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229920001002 functional polymer Polymers 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N DMSO-d6 Substances [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000002784 cytotoxicity assay Methods 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- ADRVRLIZHFZKFE-UHFFFAOYSA-N ethanediperoxoic acid Chemical compound OOC(=O)C(=O)OO ADRVRLIZHFZKFE-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000005909 tumor killing Effects 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- OAVCWZUKQIEFGG-UHFFFAOYSA-O 2-(5-methyl-2H-tetrazol-1-ium-1-yl)-1,3-thiazole Chemical compound CC1=NN=N[NH+]1C1=NC=CS1 OAVCWZUKQIEFGG-UHFFFAOYSA-O 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical group CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229920000547 conjugated polymer Polymers 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polyethers (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a photodynamic enhanced polymer nanogel, a preparation method and application thereof, belonging to the technical field of biomedical high molecular materials, wherein the polymer nanogel is prepared from a water-soluble polyethylene glycol monomethyl ether derivative, a porphyrin derivative and oxalyl chloride by a one-step method; under the tumor microenvironment with high expression of hydrogen peroxide, the carbonyl group of the cross-linking agent in the polymer nanogel is subjected to H2O2Nucleophilic attack of (2) to give (2)The decomposition of the intermediate promotes energy to be transferred to a receptor photosensitizer through chemiluminescence resonance energy transfer, so that the photodynamic efficiency of the photosensitizer is improved, and the tumor growth is better inhibited. The polymer nanogel has the advantages of simple synthetic route and capability of enabling the polymer to participate in the process of photodynamic energy conversion to improve the photodynamic treatment effect of the unit photosensitizer. The invention avoids the construction process of the biological nano particle assembly and has great advantages in the aspect of subsequent production and application.
Description
Technical Field
The invention relates to the technical field of biomedical high molecular materials, in particular to a photodynamic enhanced polymer nanogel, a preparation method and application thereof.
Background
With the advent of advanced polymerization methods such as living/controlled radical polymerization and click chemistry, the synthesis of porphyrin-containing polymers via covalent bonding has greatly evolved. The functional polymer containing porphyrin has definite macromolecular structure, unique self-assembly shape and special photochemical and photophysical properties, and has important application in the fields of catalysis, solar cells, biomedicine, environmental science and the like. In particular, the use of porphyrin-based photosensitizers or porphyrin-conjugated polymers in the field of photodynamic therapy (PDT). (Angew. chem. int.Ed.2018, 57: 16354-16358)
Although the FDA has approved porphyrins and derivatives as second-generation photosensitizers for clinical photodynamic therapy, the problems of shallow treatment depth, hypoxic tumor microenvironment, photosensitive side effects and the like still exist. To solve these problems, researchers have designed porphyrin-based polymer nano-phototherapy systems, but the synthetic routes and processes of these systems are relatively complex, limiting their wide spread and increasing the cost of treatment. How to design a functional polymer containing porphyrin, which is simple in synthesis and can solve the problems is the central importance of the development of the second-generation photosensitizer. On the other hand, the polymer framework of the current porphyrin-based functional polymer often exists only as a load, and the polymer itself has very limited functions, and often only plays a role in assembling, encapsulating or conjugating small-molecule functional groups to improve the water solubility and arrangement mode of the photosensitizer. How to make polymers participate in the process of photodynamic energy conversion and improve the photodynamic treatment effect of a unit photosensitizer is a problem which is rarely and rarely but is very worthy of being researched at present.
Chemiluminescence is a reaction process that converts chemical reaction energy into light energy at room temperature. Peroxyoxalate chemiluminescent systems, which are composed mainly of oxalate, hydrogen peroxide and fluorescent agent, are considered to be one of the most effective chemical (non-biological) luminescent systems due to their high luminous efficiency and high intensity. At present, although peroxyoxalate chemiluminescence systems are reported to enhance fluorescent molecular in vivo imaging (ACS Nano 2020,14,3696-3702), no polymeric gel containing oxalate, porphyrin and other fluorescent molecules, which provides photodynamic additional activation energy transfer sites by using hydrogen peroxide or other peroxides highly expressed in tumor microenvironment, is reported.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention provides a photodynamic enhancement type polymer nanogel, a preparation method and application thereof.
The invention is realized by the following technical scheme:
a photodynamic enhancement type polymer nanogel has a structure shown in a formula (I) or a formula (II), and is prepared from a water-soluble polyethylene glycol monomethyl ether derivative, a porphyrin derivative and oxalyl chloride by a one-step method;
wherein m is an integer, and m is more than or equal to 20 and less than or equal to 200;
the structural formula of the porphyrin derivative is as follows:
preferably, the porphyrin derivative is tetrahydroxyhexyl ether phenyl porphyrin or tetraaminophenyl porphyrin.
Preferably, the polyethylene glycol monomethyl ether derivative is polyethylene glycol monomethyl ether or aminated polyethylene glycol monomethyl ether.
The invention also provides a preparation method of the photodynamic reinforced polymer nanogel, which comprises the following steps:
in the presence of a catalyst, an acid-binding agent and a solvent, performing nucleophilic substitution reaction on the porphyrin derivative, the polyethylene glycol monomethyl ether derivative and oxalyl chloride, and preparing the polymer nanogel by a one-step method.
The molar ratio of the porphyrin derivative, the polyethylene glycol monomethyl ether derivative and the oxalyl chloride is a: n: 20 to 25 x (n + a), wherein n is 1 to 4 x a.
Preferably, the porphyrin derivative is tetrahydroxyhexyl ether phenyl porphyrin or tetraaminophenyl porphyrin; the catalyst is 4-dimethylamino pyridine; the polyethylene glycol monomethyl ether derivative is polyethylene glycol monomethyl ether or aminated polyethylene glycol monomethyl ether; the acid-binding agent is potassium carbonate or triethylamine; the solvent is anhydrous dichloromethane, anhydrous dimethyl sulfoxide or anhydrous N, N-dimethylformamide; the reaction temperature is 0-10 ℃, and the reaction time is 12-72 h.
Preferably, the tetrahydroxyhexyl ether phenyl porphyrin is prepared by the following method:
under the condition that a solvent and a catalyst exist, mixing tetrahydroxyphenyl porphyrin and 6-chloro-1-hexanol according to a certain proportion, washing an obtained reaction product with a sodium hydroxide solution and deionized water in sequence, adjusting the pH value to 7-8, performing suction filtration on the washed reaction product with a Buchner funnel to obtain a dark purple solid, and performing suction drying in a vacuum dryer to obtain tetrahydroxyhexyl ether phenyl porphyrin, wherein the reaction equation is as follows:
preferably, the catalyst is sodium iodide, and the solvent is one or more of anhydrous tetrahydrofuran, anhydrous N, N-dimethylformamide or N-methylpyrrolidone. The reaction temperature is 120-160 ℃; the reaction time is 12-36 h.
Preferably, the molar ratio of the tetrahydroxyphenylporphyrin to 6-chloro-1-hexanol is 1: 1 to 10.
The structural formula of the tetrahydroxyphenyl porphyrin is shown as a formula VII;
the invention also provides application of the photodynamic enhanced polymer nanogel in preparation of antitumor drugs.
The preparation principle of the photodynamic enhanced polymer nanogel is as follows:
the method is characterized in that a perexalate bond or a pereoxamide bond is required to exist in the nanogel as a linker to meet the experimental design concept, so that both porphyrin derivatives and polyethylene glycol monomethyl ether derivatives carry hydroxyl groups as characteristic reaction groups, and the acid chloride group of oxalyl chloride are subjected to nucleophilic substitution condensation reaction to remove hydrogen chloride to generate the polymer nanogel which is crosslinked by the perexalate bond and has the structure shown in the formula (I); the porphyrin derivative and the polyethylene glycol monomethyl ether derivative are designed by the same concept, both have amino as characteristic reactive groups, and the acyl chloride group of oxalyl chloride and the amino carry out nucleophilic substitution condensation reaction to remove hydrogen chloride to generate the polymer nanogel with the structure of the formula (II) and crosslinked by the oxamide bond. Together forming a series of photodynamically enhanced polymer nanogels with crosslinking sites that can respond to strong oxidants. The reaction equation is as follows:
compared with the prior art, the invention has the following beneficial effects:
the invention provides a photodynamic enhanced polymer nanogel which can be prepared in H2O2In a high-expression tumor microenvironment, the carbonyl group of oxalate or oxamide in the structure of formula (I) or formula (II) is subjected to H2O2The intermediate is decomposed to promote energy to be transferred to acceptor fluorescent molecules through Chemiluminescence Resonance Energy Transfer (CRET), so that the photodynamic efficiency of the unit photosensitizer is improved, and the tumor growth is better inhibited. Such beneficial effects can be obtained by combining the cytotoxicity of MTT cytotoxicity assays between different concentration gradients of each group with or without light exposureIt was demonstrated that, at the same time, the present invention demonstrated higher intracellular ROS production by flow cytometry for this nanogel compared to the original photosensitizer group and the control group under the same conditions. On the other hand, the synthesis method provided by the invention is simple and rapid in synthesis process, the construction process of the biological nanoparticle assembly is avoided by utilizing the one-step method to prepare the nanoparticles, and the method has great advantages in the aspect of subsequent production and application.
Drawings
FIG. 1 is a nuclear magnetic resonance hydrogen spectrum of a long alkyl chain-containing four-arm phenyl porphyrin derivative TOPP-C6OH4 prepared in example 1 of the present invention;
FIG. 2 is the nuclear magnetic resonance hydrogen spectrum of the polymer nanogel TAPP-NGT prepared in example 11 of the invention in heavy water;
FIG. 3 shows polymer nanogel TAPP-NGT prepared in example 11 of the invention in DMSO-d6Nuclear magnetic resonance hydrogen spectrum;
FIG. 4 is a nuclear magnetic resonance hydrogen spectrum of TOPPNPS in heavy water of the polymer nanogel prepared in example 3 of the invention;
FIG. 5 shows the polymer nanogel TOPPNPS prepared in example 3 of the invention in DMSO-d6Nuclear magnetic resonance hydrogen spectrum;
FIG. 6 is an infrared spectrum of TOPPNPS, a polymer nanogel prepared in example 3 of the invention;
FIG. 7 is a graph showing the dynamic light scattering of the polymer nanogel TOPPNPS prepared in example 3 of the invention;
FIG. 8 is a transmission electron microscope image of TOPPNPS polymer nanogel prepared in example 3 of the invention;
FIG. 9 is an in vitro ROS ultraviolet spectrum of the polymer nanogel TOPPNPS prepared in example 3 of the invention cultured in PBS for seven points taken for 30 min;
FIG. 10 is the cell survival rate of B16-F10 murine melanoma cells according to example 11 with increasing concentration of photosensitizer contained in TAPP-NGT;
FIG. 11 is the survival rate of B16-F10 murine melanoma cells as compared to TOPPNPS containing photosensitizer at increasing concentration in example 3;
FIG. 12 is a flow cytometric map of the intracellular internalization of murine melanoma from B16-F10 for 4 hours in example 11, reflecting the intracellular ROS production of different materials.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A photodynamic enhancement type polymer nanogel has a structure shown in a formula (I) or a formula (II), and is prepared by a one-step method from water-soluble polyethylene glycol monomethyl ether, porphyrin derivatives and oxalyl chloride;
wherein m is an integer, and m is more than or equal to 20 and less than or equal to 200;
the porphyrin derivative has the following structure:
the invention also provides a preparation method of the polymer nanogel, which comprises the following steps:
in the presence of a catalyst, an acid-binding agent and a solvent, matching tetrahydroxyhexyl ether phenyl porphyrin or tetraaminophenyl porphyrin with a structure shown in formula (V) or formula (VI) with polyethylene glycol monomethyl ether or aminated polyethylene glycol monomethyl ether in different proportions and oxalyl chloride to obtain the polymer nanogel with the structure shown in formula (I) or formula (II) through a one-step method.
In the structures shown in the formulas (I) to (VI), the corresponding bond at the wavy position is a connecting bond of the groups and is connected with the main structure.
In certain embodiments of the present invention, 20 ≦ m ≦ 200.
In certain embodiments of the invention, n is a, 2a, 3a, or 4 a; m is 23, 45 or 113.
The polymer nanogel provided by the invention is synthesized by a simple one-step method. The material can be in H2O2In a high-expression tumor microenvironment, the carbonyl group of oxalate or oxamide is subjected to H2O2The intermediate is decomposed to promote energy to be transferred to acceptor fluorescent molecules through Chemiluminescence Resonance Energy Transfer (CRET), so that the photodynamic efficiency of the unit photosensitizer is improved, and the tumor growth is better inhibited.
In certain embodiments of the present invention, the sum of the amounts of porphyrin derivative having the structure of formula (i) or formula (ii) and the amount of monomethyl ether polyglycol derivative, and the amount of oxalyl chloride, in a ratio of 1: 20-25;
in certain embodiments of the invention, the solvent comprises anhydrous dichloromethane, anhydrous dimethyl sulfoxide, or anhydrous N, N-dimethylformamide; the amount of the solvent used is not particularly limited, and the porphyrin derivative, the polyethylene glycol monomethyl ether derivative and the oxalyl chloride can be dissolved.
In certain embodiments of the invention, the catalyst is DMAP; the acid-binding agent is potassium carbonate or triethylamine.
In some embodiments of the invention, the temperature of the reaction is 0-10 ℃; the reaction time is 12-72 h.
In some embodiments of the invention, the nucleophilic substitution reaction is performed under ice bath conditions, and the reaction flask needs to be vacuum-dried before the reaction.
In some embodiments of the present invention, after the condensation of the polymer having the structure of formula (i) or formula (ii) in a solvent is completed, the method further comprises: the reaction product was dialyzed and lyophilized. The method of dialysis and lyophilization is not particularly limited in the present invention, and those familiar to those skilled in the art can be used.
In certain embodiments of the present invention, the long alkyl chain-containing four-arm phenylporphyrin derivative having the structure of formula (v) is prepared by the following method:
under the action of a catalyst, the phenolic hydroxyl of the tetrahydroxyphenyl porphyrin with the structure shown in the formula (VII) is more easily deprotonated to react with 6-chloro-1-hexanol in a solvent to obtain the long alkyl chain-containing four-arm phenyl porphyrin derivative with the structure shown in the formula (V); the catalyst is sodium iodide; the solvent is one or more of anhydrous tetrahydrofuran, anhydrous N, N-dimethylformamide and N-methylpyrrolidone;
in certain embodiments of the invention, the molar ratio of tetrahydroxyphenyl porphyrin having the structure of formula (VII) to 6-chloro-1-hexanol is 1: 1 to 10.
In some embodiments of the invention, the temperature of the reaction is 120-160 ℃; the reaction time is 12-36 h.
In some embodiments of the present invention, after the reaction of the four-arm phenyl porphyrin derivative containing long alkyl chain in the solvent is completed, the method further comprises: and washing the obtained reaction product with a sodium hydroxide solution and deionized water in sequence, and adjusting the pH value to 7-8. In certain embodiments of the present invention, the number of washes is 3 or more.
In some embodiments of the present invention, after the washing process is finished, the method further includes: and (3) carrying out suction filtration on the washed reaction product by using a Buchner funnel to obtain a dark purple solid, and carrying out suction drying in a vacuum drier to obtain the porphyrin derivative with the structure shown in the formula (V).
The source of the above-mentioned raw materials is not particularly limited in the present invention, and may be generally commercially available.
The invention also provides application of the polymer nanogel or the polymer nanogel prepared by the preparation method in preparation of antitumor drugs.
The present invention will be described in further detail with reference to examples.
Example 1
Synthesis of a long alkyl chain-containing four-armed phenylporphyrin derivative having the structure of formula (v):
0.678g (0.001mol) of tetrahydroxyphenylporphyrin was weighed out and dissolved in 100mL of DMF, and 5g of NaI (0.0035mol) was added thereto under ice bath conditions to activate the resulting mixture. After activation, the reaction was stirred at 25 ℃ for 6 h. The reaction was then transferred to an oil bath at 151 ℃ under reflux. To the closed system, 1.4mL (0.01mol) of 6-chloro-1-hexanol was added dropwise using a syringe, and the reaction was continued under reflux for 12 hours. After the reaction was stopped, the reaction solution was poured into chilled deionized water, and sodium hydroxide was slowly added to observe the color change. Washing with deionized water for three times, vacuum-filtering with Buchner funnel to obtain dark purple solid, and vacuum-drying in vacuum drier to obtain tetrahydroxyhexyl ether phenyl porphyrin TOPP-C6OH 4; the reaction equation is as follows:
the structure of the obtained long alkyl chain-containing four-arm phenyl porphyrin derivative TOPP-C6OH4 is characterized, and the result is shown in FIG. 1. FIG. 1 shows the NMR spectrum of TOPP-C6OH4, a four-arm phenyl porphyrin derivative with long alkyl chain, prepared in example 1 of the present invention.
Example 2
Synthesis of a long alkyl chain-containing four-armed phenylporphyrin derivative having the structure of formula (v):
0.678g (0.001mol) of tetrahydroxyphenylporphyrin was weighed out and dissolved in 100mL of DMF, and activated by adding 5g of NaI (0.0035mol) in an ice bath. After activation, the reaction was stirred at 25 ℃ for 6 h. The reaction was then transferred to an oil bath at 151 ℃ under reflux. 0.7mL (0.005mol) of 6-chloro-1-hexanol was added dropwise to the closed system using a syringe, and the reaction was continued under reflux for 24 hours. After the reaction was stopped, the reaction solution was poured into chilled deionized water, and sodium hydroxide was slowly added to observe the color change. And washing with deionized water for three times, performing suction filtration by using a Buchner funnel to obtain a dark purple solid, and performing suction drying in a vacuum drier to obtain the tetrahydroxyhexyl ether phenyl porphyrin.
Example 3
Synthesis of a polyoxalate-crosslinked nanogel having the structure of formula (i) wherein n ═ a:
anhydrous and anaerobic treatment is carried out on a reaction device, 0.5g (0.0001mol) of methoxypolyethylene glycol (mPEG5000, molecular weight of 5000) is weighed, and azeotropic reflux is carried out for 4h by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.5mL (0.005mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS. The reaction equation is as follows:
the polymer nanogel TOPPNPS obtained above was characterized, and the results are shown in fig. 4 and 5. FIG. 4 is the NMR spectrum of the polymer-process nanogel TOPPNPS prepared in example 3 of the invention in heavy water. FIG. 5 shows the NMR spectrum of TOPPNPS polymer nanogel prepared in example 3 of the invention in DMSO-d 6. As can be seen from fig. 4 and 5, polymer nanogel TOPPNPS has been successfully synthesized and has constituted a nanoscale assembly. The analysis of the infrared spectrogram of FIG. 6 assists this argument.
FIG. 7 is a graph showing the dynamic light scattering of the polymer nanogel TOPPNPS prepared in example 3 of the invention; FIG. 8 is a transmission electron microscope image of TOPPNPS polymer nanogel prepared in example 3 of the invention. Both together indicate that the nanoparticles are stable and have a size between 120-200 nm.
FIG. 9 is an in vitro ROS ultraviolet spectrum of the polymer nanogel TOPPNPS prepared in example 3 of the invention cultured in PBS for seven points taken for 30 min; the polymer rice gel TOPPNPS can continuously generate ROS under illumination and can be used as a photodynamic phototherapy system.
The antitumor activity of polymer nanogel TOPPNPS was examined by cytotoxicity assay:
the polymer nanogel TOPPNPS prepared in the embodiment 3 of the invention is co-cultured with B16-F10 murine melanoma cells, and is evaluated by adopting an MTT (methyl thiazolyl tetrazolium) experiment:
the corresponding cells were first seeded at a density of 7000 cells/well (suspended in 200L DMEM medium) in 96-well plates and incubated for 24h at 37 ℃ in a cell incubator. The next day, the corresponding polymer nanogel TOPPNPS was dissolved in fresh DMEM medium and diluted to different concentrations in a gradient, the medium from the previous day was discarded, DMEM containing different concentrations of polymer nanogel TOPPNPS was added and incubation continued in the cell culture chamber at 37 ℃ for 24 h. MTT solution (final concentration 0.5mg/mL) was then added to each well and incubation continued at 37 ℃ for 4 h. The liquid in the well plate was discarded, and 150L of DMSO was added to each well, respectively, to dissolve purple formazan crystals. Finally, the absorbance of each well at 492nm is measured by a microplate reader (Tecan, Switzerland), and the cell survival rate can be calculated by comparing the absorbance value of the experimental group with that of the control group.
FIG. 11 is the survival rate of B16-F10 murine melanoma cells as compared to TOPPNPS containing photosensitizer at increasing concentration in example 3; the non-light group almost does not kill, the tumor killing rate of the light group polymer nanogel TOPPNPS is obviously improved in each concentration gradient compared with that of a pure photosensitizer treatment group, and the polymer nanogel TOPPNPS is proved to cause that the photodynamic efficiency of a unit photosensitizer is comprehensively and obviously improved, so that the idea of better anti-tumor effect is played.
Example 4
Synthesis of a polyoxalate cross-linked nanogel having the structure of formula (i) wherein n ═ 2 a:
anhydrous and anaerobic treatment is carried out on a reaction device, 1.0g (0.0002mol) of polyethylene glycol monomethyl ether (mPEG5000, molecular weight of 5000) is weighed, and toluene is used as a solvent to carry out azeotropic reflux for 4h for removing water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in an ice bath and protected by nitrogen, 0.7mL (0.0075mol) of oxalyl chloride is slowly added dropwise by a syringe, and after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS.
Example 5
Synthesis of a polyoxalate cross-linked nanogel having the structure of formula (i) wherein n ═ 3 a:
anhydrous and anaerobic treatment is carried out on a reaction device, 1.5g (0.0003mol) of polyethylene glycol monomethyl ether (mPEG5000, molecular weight 5000) is weighed, and toluene is used as a solvent for azeotropic reflux for 4h to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.9mL (0.01mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS.
Example 6
Synthesis of a polyoxalate cross-linked nanogel having the structure of formula (i) wherein n ═ 4 a:
anhydrous and anaerobic treatment is carried out on a reaction device, 1.0g (0.0002mol) of polyethylene glycol monomethyl ether (mPEG5000, molecular weight of 5000) is weighed, and toluene is used as a solvent to carry out azeotropic reflux for 4h for removing water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in an ice bath and protected by nitrogen, 0.7mL (0.0075mol) of oxalyl chloride is slowly added dropwise by a syringe, and after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS.
Example 7
Synthesis of a polyoxalate cross-linked nanogel having the structure of formula (i) wherein n ═ a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.2g (0.0001mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.5mL (0.005mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS.
Example 8
Synthesis of a polyoxalate cross-linked nanogel having the structure of formula (i) wherein n ═ 2 a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.4g (0.0002mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in an ice bath and protected by nitrogen, 0.7mL (0.0075mol) of oxalyl chloride is slowly added dropwise by a syringe, and after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS.
Example 9
Synthesis of a polyoxalate cross-linked nanogel having the structure of formula (i) wherein n ═ 3 a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.6g (0.0003mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.9mL (0.01mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS.
Example 10
Synthesis of a polyoxalate cross-linked nanogel having the structure of formula (i) wherein n ═ 4 a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.8g (0.0004mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.113g (0.0001mol) of tetrahexyl-terminated porphyrin derivative with the structure of the formula (V) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 1.1mL (0.0125mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the reaction is stirred and carried out for 24 hours. And after the reaction is finished, settling with frozen ether, dialyzing, and freeze-drying to obtain the polymer nanogel TOPPNPS.
Example 11
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ a:
anhydrous and anaerobic treatment is carried out on a reaction device, 0.5g (0.0001mol) of methoxypolyethylene glycol (mPEG5000, molecular weight of 5000) is weighed, and azeotropic reflux is carried out for 4h by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of the formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.5mL (0.005mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT. The reaction equation is as follows:
the polymer nanogel TAPP-NGT obtained in the above way is characterized, and the results are shown in figure 2 and figure 3. FIG. 2 shows the NMR spectrum of the polymer nanogel TAPP-NGT prepared in example 11 of the invention in heavy water. FIG. 3 is the nuclear magnetic resonance hydrogen spectrum of the polymer nanogel TAPP-NGT prepared in example 11 of the invention in DMSO-d 6. From fig. 2 and 3, it can be seen that the polymer nanogel TAPP-NGT has been successfully synthesized and has been constructed into nanoscale assemblies.
FIG. 10 is the cell survival rate of B16-F10 murine melanoma cells according to example 11 with increasing concentration of photosensitizer contained in TAPP-NGT; the polymer nanogel TAPP-NGT in the non-illumination group is almost not killed, the tumor killing rate of the polymer nanogel TAPP-NGT in the illumination group is obviously improved in each concentration gradient compared with that of a pure photosensitizer treatment group, and the idea that the photodynamic efficiency of a unit photosensitizer caused by the polymer nanogel TAPP-NGT is comprehensively and obviously improved, and a better anti-tumor effect is achieved.
FIG. 12 is a flow cytometric map of the intracellular internalization of murine melanoma from B16-F10 for 4 hours in example 11, reflecting the intracellular ROS production of different materials. The abscissa corresponds to the fluorescence intensity of the DCF-DH probe, the test can reflect the ROS production in cells, and the result shows that the ROS production of the polymer nanogel TAPP-NGT is remarkably improved compared with that of a pure photosensitizer treatment group, so that the photodynamic efficiency of a unit photosensitizer caused by the polymer nanogel TAPP-NGT is comprehensively and remarkably improved, and a better anti-tumor effect is achieved.
Example 12
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ 2 a:
anhydrous and anaerobic treatment is carried out on a reaction device, 1g (0.0002mol) of polyethylene glycol monomethyl ether (mPEG5000, molecular weight 5000) is weighed, and toluene is used as a solvent to carry out azeotropic reflux for 4h for removing water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of the formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in an ice bath and protected by nitrogen, 0.7mL (0.0075mol) of oxalyl chloride is slowly added dropwise by a syringe, and after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT.
Example 13
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ 3 a:
anhydrous and anaerobic treatment is carried out on a reaction device, 1.5g (0.0003mol) of polyethylene glycol monomethyl ether (mPEG5000, molecular weight 5000) is weighed, and toluene is used as a solvent for azeotropic reflux for 4h to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of the formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.9mL (0.01mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT.
Example 14
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ 4 a:
anhydrous and anaerobic treatment is carried out on a reaction device, 2g (0.0004mol) of polyethylene glycol monomethyl ether (mPEG5000, molecular weight of 5000) is weighed, and toluene is used as a solvent to carry out azeotropic reflux for 4h for removing water. The toluene solvent is drained, 30mL of anhydrous dichloromethane is added at room temperature to be fully dissolved, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 1.1mL (0.0125mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the reaction is stirred and carried out for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT.
Example 15
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.2g (0.0001mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of the formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.5mL (0.005mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT.
Example 16
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ 2 a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.4g (0.0002mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of the formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in an ice bath and protected by nitrogen, 0.7mL (0.0075mol) of oxalyl chloride is slowly added dropwise by a syringe, and after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT.
Example 17
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ 3 a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.6g (0.0003mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of the formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 0.9mL (0.01mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the mixture is stirred and reacted for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT.
Example 18
Synthesis of a polyoxamide cross-linked nanogel having the structure of formula (ii) wherein n ═ 4 a:
the reaction device is subjected to anhydrous and anaerobic treatment, 0.8g (0.0004mol) of polyethylene glycol monomethyl ether (mPEG2000, molecular weight 2000) is weighed, and the mixture is subjected to azeotropic reflux for 4 hours by taking toluene as a solvent to remove water. The toluene solvent is drained, 20mL of anhydrous dichloromethane is added at room temperature to fully dissolve the toluene solvent, and 0.068g (0.0001mol) of tetraaminophenylporphyrin with the structure of the formula (VI) and an acid-binding agent are added under the protection of nitrogen. The mixture is cooled in ice bath and protected by nitrogen, 1.1mL (0.0125mol) of oxalyl chloride is added dropwise and slowly by a syringe, after 4 hours of reaction, the temperature is raised to 25 ℃, and the reaction is stirred and carried out for 24 hours. After the reaction is finished, using frozen ether for settling, dialyzing and freeze-drying to obtain the polymer nanogel TAPP-NGT.
From the above embodiments, the present invention provides a polymer nanogel, a preparation method and applications thereof. The nanogel has a structure shown in a formula (I) or a formula (II): wherein m is more than or equal to 20 and less than or equal to 200. The nanogel provided by the invention is synthesized by a simple one-step method. The material can be in H2O2In a high-expression tumor microenvironment, the carbonyl group of oxalate or oxamide is subjected to H2O2The intermediate is decomposed to promote energy to be transferred to acceptor fluorescent molecules through Chemiluminescence Resonance Energy Transfer (CRET), so that the photodynamic efficiency of the unit photosensitizer is comprehensively and remarkably improved, and a better anti-tumor effect is achieved.
The above description of the embodiments is only intended to facilitate the understanding of the method of the invention and its core idea. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (9)
1. A photodynamic enhancement type polymer nanogel is characterized by having a structure shown in a formula (I) or a formula (II) and being prepared from a water-soluble polyethylene glycol monomethyl ether derivative, a porphyrin derivative and oxalyl chloride through a one-step method;
wherein m is an integer, and m is more than or equal to 20 and less than or equal to 200;
the structural formula of the porphyrin derivative is as follows:
2. the photodynamic reinforced polymer nanogel of claim 1, wherein the porphyrin derivative is tetrahydroxyhexyl ether phenyl porphyrin or tetraaminophenyl porphyrin.
3. The photodynamic reinforced polymer nanogel of claim 1, wherein the polyethylene glycol monomethyl ether derivative is polyethylene glycol monomethyl ether or aminated polyethylene glycol monomethyl ether.
4. The method of claim 1, comprising the steps of:
in the presence of a catalyst, an acid-binding agent and a solvent, performing nucleophilic substitution reaction on the porphyrin derivative, the polyethylene glycol monomethyl ether derivative and oxalyl chloride, and preparing the polymer nanogel by a one-step method.
The molar ratio of the porphyrin derivative, the polyethylene glycol monomethyl ether derivative and the oxalyl chloride is a: n: 20 to 25 x (n + a), wherein n is 1 to 4 x a.
5. The method for preparing the photodynamic reinforced polymer nanogel as recited in claim 4, wherein the porphyrin derivative is tetrahydroxyhexyl ether phenyl porphyrin or tetraaminophenyl porphyrin; the catalyst is 4-dimethylamino pyridine; the polyethylene glycol monomethyl ether derivative is polyethylene glycol monomethyl ether or aminated polyethylene glycol monomethyl ether; the acid-binding agent is potassium carbonate or triethylamine; the solvent is anhydrous dichloromethane, anhydrous dimethyl sulfoxide or anhydrous N, N-dimethylformamide; the reaction temperature is 0-10 ℃, and the reaction time is 12-72 h.
6. The method for preparing the photodynamic reinforced polymer nanogel as recited in claim 4, wherein the tetrahydroxyhexyl ether phenyl porphyrin is prepared by the following steps:
under the condition that a solvent and a catalyst exist, mixing tetrahydroxyphenyl porphyrin and 6-chloro-1-hexanol according to a certain proportion, washing an obtained reaction product with a sodium hydroxide solution and deionized water in sequence, adjusting the pH value to 7-8, performing suction filtration on the washed reaction product with a Buchner funnel to obtain a dark purple solid, and performing suction drying in a vacuum dryer to obtain tetrahydroxyhexyl ether phenyl porphyrin, wherein the reaction equation is as follows:
7. the method of claim 6, wherein the catalyst is sodium iodide, and the solvent is one or more of anhydrous tetrahydrofuran, anhydrous N, N-dimethylformamide, and N-methylpyrrolidone. The reaction temperature is 120-160 ℃; the reaction time is 12-36 h.
9. the use of the photodynamic amplification type polymer nanogel as defined in claim 1 in the preparation of an antitumor drug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110684381.XA CN113440612B (en) | 2021-06-21 | 2021-06-21 | Photodynamic enhanced polymer nanogel, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110684381.XA CN113440612B (en) | 2021-06-21 | 2021-06-21 | Photodynamic enhanced polymer nanogel, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113440612A true CN113440612A (en) | 2021-09-28 |
CN113440612B CN113440612B (en) | 2022-10-14 |
Family
ID=77811952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110684381.XA Expired - Fee Related CN113440612B (en) | 2021-06-21 | 2021-06-21 | Photodynamic enhanced polymer nanogel, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113440612B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116143792A (en) * | 2023-02-14 | 2023-05-23 | 浙江大学 | Active oxygen response non-light source photodynamic therapy photosensitive molecule and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2150278A1 (en) * | 2007-04-23 | 2010-02-10 | Korea Institute of Science and Technology | Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy |
KR20120045155A (en) * | 2010-10-29 | 2012-05-09 | 가톨릭대학교 산학협력단 | Polymer conjugated photosensitizer for photodynamic therapy and preparation method thereof |
CN104151567A (en) * | 2014-07-16 | 2014-11-19 | 东北师范大学 | Preparation method of metal coordination supermolecular nanogel |
CN108892743A (en) * | 2018-05-28 | 2018-11-27 | 南京工业大学 | Nano photosensitizer for photodynamic antibacterial, preparation method and application thereof |
CN109481680A (en) * | 2019-01-09 | 2019-03-19 | 中国科学院长春光学精密机械与物理研究所 | A kind of inside and outside composite Nano photosensitizer and its preparation method and application minored |
CN109675031A (en) * | 2019-01-31 | 2019-04-26 | 苏州大学 | A kind of optical dynamic therapy pharmaceutical composition and preparation method thereof and a kind of hydrogel photosensitizer |
-
2021
- 2021-06-21 CN CN202110684381.XA patent/CN113440612B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2150278A1 (en) * | 2007-04-23 | 2010-02-10 | Korea Institute of Science and Technology | Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy |
KR20120045155A (en) * | 2010-10-29 | 2012-05-09 | 가톨릭대학교 산학협력단 | Polymer conjugated photosensitizer for photodynamic therapy and preparation method thereof |
CN104151567A (en) * | 2014-07-16 | 2014-11-19 | 东北师范大学 | Preparation method of metal coordination supermolecular nanogel |
CN108892743A (en) * | 2018-05-28 | 2018-11-27 | 南京工业大学 | Nano photosensitizer for photodynamic antibacterial, preparation method and application thereof |
CN109481680A (en) * | 2019-01-09 | 2019-03-19 | 中国科学院长春光学精密机械与物理研究所 | A kind of inside and outside composite Nano photosensitizer and its preparation method and application minored |
CN109675031A (en) * | 2019-01-31 | 2019-04-26 | 苏州大学 | A kind of optical dynamic therapy pharmaceutical composition and preparation method thereof and a kind of hydrogel photosensitizer |
Non-Patent Citations (3)
Title |
---|
JIAXUN JIANG等: ""Chiral recognition of amino acid esters by a novel oxalic amide-linked bisporphyrin"", 《DALTON TRANS.》 * |
冯志强: ""草酰胺键联双卟啉锌的合成及其对氨基酸酯的手性识别"", 《苏州大学硕士学位论文》 * |
周坤等: ""具有酸碱响应性能的卟啉修饰壳聚糖形状记忆水凝胶的制备和性能研究"", 《化工新型材料》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116143792A (en) * | 2023-02-14 | 2023-05-23 | 浙江大学 | Active oxygen response non-light source photodynamic therapy photosensitive molecule and preparation method and application thereof |
CN116143792B (en) * | 2023-02-14 | 2024-04-05 | 浙江大学 | Active oxygen response non-light source photodynamic therapy photosensitive molecule and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN113440612B (en) | 2022-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qi et al. | Dragonfly-shaped near-infrared AIEgen with optimal fluorescence brightness for precise image-guided cancer surgery | |
Jing et al. | A reduction-responsive polypeptide nanogel encapsulating NIR photosensitizer for imaging guided photodynamic therapy | |
CN109096170B (en) | Near-infrared dye, targeted imaging agent, nano-carrier, anti-cancer drug and application thereof | |
Lu et al. | Water-soluble BODIPY-conjugated glycopolymers as fluorescent probes for live cell imaging | |
CN110041475B (en) | Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application | |
Chen et al. | The self-assembly of a hybrid photosensitizer for the synergistically enhanced photodynamic/photothermal therapy | |
CN111689955A (en) | Naphthothiadiazole free radical type photosensitizer and preparation method and application thereof | |
CN103396554A (en) | Hydrogel, preparation method thereof and applications | |
CN113440612B (en) | Photodynamic enhanced polymer nanogel, preparation method and application thereof | |
Xue et al. | Fluorescence resonance energy transfer enhanced photothermal and photodynamic antibacterial therapy post a single injection | |
Cui et al. | Water-soluble sulfonate porphyrin functionalized hyaluronic acid with comb-like structure: potential photosensitizers for photodynamic therapy | |
Yu et al. | A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy | |
Liu et al. | Oxygen self-sufficient amphiphilic polypeptide nanoparticles encapsulating bodipy for potential near infrared imaging-guided photodynamic therapy at low energy | |
Lu et al. | BODIPY-based macromolecular photosensitizer with selective recognition and enhanced anticancer efficiency | |
Men et al. | Photo cleavable thioacetal block copolymers for controlled release | |
Li et al. | A novel cross-linked nanoparticle with aggregation-induced emission properties for cancer cell imaging | |
Guo et al. | Facile construction of luminescent supramolecular assemblies with aggregation-induced emission feature through supramolecular polymerization and their biological imaging | |
Gao et al. | Water-soluble dendritic polyaspartic porphyrins: potential photosensitizers for photodynamic therapy | |
CN111592634B (en) | Photoreduction self-degradation polymer and preparation method and application thereof | |
Wen et al. | Folic acid functionalized aggregation-induced emission nanoparticles for tumor cell targeted imaging and photodynamic therapy | |
CN114316084B (en) | AIE functionalized modified chitin material capable of being fluorescently traced, preparation method and application | |
CN116854713A (en) | Fluoroboron dipyrrole type photothermal nanomaterial as well as synthesis method and application thereof | |
CN108912327B (en) | Degradable living cell fluorescence imaging material with water-soluble unconjugated structure, and preparation method and application thereof | |
CN107929734B (en) | Nano medicine for controllable photodynamic therapy and preparation method thereof | |
JP2021528482A (en) | Oxazine compounds and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20221014 |